Patricia Ernst
Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myeloid-Lymphoid Leukemia Protein | 30 | 2025 | 70 | 8.750 |
Why?
| | Histone-Lysine N-Methyltransferase | 29 | 2025 | 136 | 7.640 |
Why?
| | Leukemia | 9 | 2025 | 240 | 2.670 |
Why?
| | Hematopoiesis | 12 | 2017 | 192 | 2.550 |
Why?
| | Hematopoietic Stem Cells | 14 | 2019 | 406 | 2.410 |
Why?
| | Gene Rearrangement | 4 | 2025 | 150 | 2.110 |
Why?
| | Gene Expression Regulation, Leukemic | 7 | 2025 | 56 | 1.570 |
Why?
| | Leukemia, Myeloid, Acute | 8 | 2021 | 630 | 1.510 |
Why?
| | Oncogene Proteins, Fusion | 7 | 2025 | 215 | 1.500 |
Why?
| | Proto-Oncogene Proteins | 8 | 2025 | 648 | 1.340 |
Why?
| | DNA-Binding Proteins | 9 | 2025 | 1502 | 1.070 |
Why?
| | Transcription Factors | 12 | 2025 | 1719 | 1.010 |
Why?
| | Histones | 6 | 2025 | 636 | 0.970 |
Why?
| | Epigenesis, Genetic | 3 | 2015 | 660 | 0.940 |
Why?
| | Neoplasm Proteins | 4 | 2017 | 434 | 0.860 |
Why?
| | Morals | 1 | 2025 | 82 | 0.860 |
Why?
| | B-Lymphocytes | 3 | 2018 | 847 | 0.670 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 80 | 0.660 |
Why?
| | Cell Transformation, Neoplastic | 4 | 2021 | 327 | 0.650 |
Why?
| | Animals | 43 | 2025 | 36940 | 0.610 |
Why?
| | Health Personnel | 1 | 2025 | 710 | 0.590 |
Why?
| | Antineoplastic Agents | 3 | 2025 | 2129 | 0.580 |
Why?
| | Proto-Oncogenes | 5 | 2005 | 29 | 0.580 |
Why?
| | Sirtuin 1 | 2 | 2015 | 30 | 0.570 |
Why?
| | Methyltransferases | 2 | 2016 | 78 | 0.560 |
Why?
| | Interleukin-7 | 1 | 2018 | 61 | 0.560 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 327 | 0.550 |
Why?
| | Mice | 34 | 2025 | 17787 | 0.550 |
Why?
| | Cell Differentiation | 9 | 2025 | 1991 | 0.550 |
Why?
| | Histone Chaperones | 1 | 2016 | 16 | 0.520 |
Why?
| | Methylation | 8 | 2025 | 230 | 0.500 |
Why?
| | Hematologic Neoplasms | 1 | 2017 | 156 | 0.470 |
Why?
| | Leukemia, Experimental | 1 | 2014 | 27 | 0.450 |
Why?
| | Cell Proliferation | 11 | 2019 | 2475 | 0.450 |
Why?
| | Helicobacter pylori | 3 | 2001 | 42 | 0.390 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 305 | 0.340 |
Why?
| | Genes, Homeobox | 3 | 2006 | 51 | 0.340 |
Why?
| | Cells, Cultured | 12 | 2019 | 4193 | 0.330 |
Why?
| | Embryo, Mammalian | 3 | 2005 | 232 | 0.320 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2004 | 860 | 0.320 |
Why?
| | Signal Transduction | 6 | 2018 | 5079 | 0.310 |
Why?
| | Chromatin | 4 | 2016 | 519 | 0.310 |
Why?
| | Mice, Inbred C57BL | 10 | 2021 | 5757 | 0.300 |
Why?
| | Interferon-alpha | 1 | 2009 | 198 | 0.280 |
Why?
| | Interleukin-10 | 2 | 2000 | 302 | 0.280 |
Why?
| | Mice, Knockout | 10 | 2021 | 3015 | 0.280 |
Why?
| | Homeodomain Proteins | 8 | 2016 | 506 | 0.280 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2019 | 289 | 0.270 |
Why?
| | Mice, Transgenic | 6 | 2019 | 2167 | 0.270 |
Why?
| | Gene Expression Regulation | 6 | 2017 | 2607 | 0.270 |
Why?
| | Pluripotent Stem Cells | 2 | 2023 | 80 | 0.270 |
Why?
| | Stem Cells | 3 | 2009 | 594 | 0.260 |
Why?
| | Tumor Suppressor Proteins | 2 | 2021 | 327 | 0.250 |
Why?
| | Carcinogenesis | 2 | 2019 | 217 | 0.250 |
Why?
| | Humans | 31 | 2025 | 137585 | 0.250 |
Why?
| | Intestinal Mucosa | 3 | 2000 | 623 | 0.230 |
Why?
| | Sweden | 1 | 2025 | 101 | 0.230 |
Why?
| | Lymphocyte Activation | 2 | 2018 | 1142 | 0.230 |
Why?
| | Oncogene Proteins | 2 | 2016 | 59 | 0.220 |
Why?
| | Trans-Activators | 3 | 2021 | 398 | 0.220 |
Why?
| | HEK293 Cells | 4 | 2021 | 730 | 0.210 |
Why?
| | Promoter Regions, Genetic | 5 | 2023 | 1250 | 0.210 |
Why?
| | Homeostasis | 3 | 2018 | 621 | 0.210 |
Why?
| | Gastric Mucosa | 2 | 2000 | 55 | 0.210 |
Why?
| | fas Receptor | 2 | 2001 | 95 | 0.210 |
Why?
| | Apoptosis | 5 | 2011 | 2553 | 0.200 |
Why?
| | Neuronal Plasticity | 2 | 2016 | 290 | 0.200 |
Why?
| | Zinc Fingers | 1 | 2002 | 50 | 0.190 |
Why?
| | Multiprotein Complexes | 2 | 2014 | 163 | 0.190 |
Why?
| | Tumor Escape | 1 | 2021 | 42 | 0.180 |
Why?
| | Chromatin Assembly and Disassembly | 2 | 2014 | 104 | 0.180 |
Why?
| | Membrane Glycoproteins | 2 | 2001 | 500 | 0.170 |
Why?
| | Antigens, CD19 | 1 | 2021 | 123 | 0.170 |
Why?
| | Antigens, Bacterial | 1 | 2001 | 127 | 0.170 |
Why?
| | Alleles | 4 | 2014 | 891 | 0.170 |
Why?
| | Intestine, Large | 1 | 2000 | 14 | 0.170 |
Why?
| | Precursor Cells, B-Lymphoid | 2 | 2018 | 40 | 0.170 |
Why?
| | Enterotoxins | 1 | 2000 | 88 | 0.160 |
Why?
| | Receptors, Interleukin | 1 | 2000 | 45 | 0.160 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2019 | 7 | 0.160 |
Why?
| | PAX7 Transcription Factor | 1 | 2019 | 13 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-bcl-6 | 1 | 2019 | 8 | 0.160 |
Why?
| | Lymphopoiesis | 2 | 2013 | 26 | 0.160 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2019 | 8 | 0.160 |
Why?
| | Cell Line | 7 | 2007 | 2847 | 0.160 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2019 | 29 | 0.160 |
Why?
| | Gene Deletion | 2 | 2019 | 391 | 0.160 |
Why?
| | Myoblasts | 1 | 2019 | 84 | 0.150 |
Why?
| | Intestine, Small | 1 | 2000 | 156 | 0.150 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 665 | 0.150 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 2 | 2011 | 31 | 0.150 |
Why?
| | Tamoxifen | 1 | 2019 | 202 | 0.150 |
Why?
| | Flow Cytometry | 5 | 2011 | 1178 | 0.140 |
Why?
| | Multigene Family | 2 | 2017 | 198 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 622 | 0.140 |
Why?
| | Enzyme Inhibitors | 1 | 2021 | 840 | 0.140 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2844 | 0.140 |
Why?
| | Female | 12 | 2025 | 73304 | 0.140 |
Why?
| | T-Lymphocyte Subsets | 1 | 2000 | 417 | 0.140 |
Why?
| | Neurons | 4 | 2016 | 1590 | 0.130 |
Why?
| | Embryonic Stem Cells | 2 | 2025 | 129 | 0.130 |
Why?
| | Cell Survival | 4 | 2019 | 1120 | 0.130 |
Why?
| | Nuclear Pore Complex Proteins | 1 | 2016 | 38 | 0.130 |
Why?
| | Protein Interaction Maps | 1 | 2016 | 48 | 0.130 |
Why?
| | Organ Specificity | 1 | 2017 | 305 | 0.130 |
Why?
| | Ventral Striatum | 1 | 2016 | 8 | 0.130 |
Why?
| | Dopamine Agents | 1 | 2016 | 19 | 0.130 |
Why?
| | Antigens, CD | 2 | 2013 | 521 | 0.130 |
Why?
| | Protein Binding | 2 | 2025 | 2224 | 0.120 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 190 | 0.120 |
Why?
| | Staphylococcus aureus | 1 | 2000 | 450 | 0.120 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2017 | 1396 | 0.120 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2013 | 138 | 0.120 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 116 | 0.120 |
Why?
| | Cell Lineage | 4 | 2013 | 350 | 0.110 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 56 | 0.110 |
Why?
| | Heterografts | 1 | 2014 | 138 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2005 | 976 | 0.110 |
Why?
| | Protein Interaction Mapping | 1 | 2014 | 109 | 0.110 |
Why?
| | CD48 Antigen | 1 | 2013 | 2 | 0.110 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2013 | 9 | 0.100 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 861 | 0.100 |
Why?
| | Leukocytosis | 1 | 2013 | 30 | 0.100 |
Why?
| | Histone Acetyltransferases | 1 | 2014 | 60 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2025 | 6079 | 0.100 |
Why?
| | Epistasis, Genetic | 1 | 2013 | 70 | 0.100 |
Why?
| | Action Potentials | 1 | 2016 | 493 | 0.100 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 219 | 0.100 |
Why?
| | T-Lymphocytes | 1 | 2001 | 1996 | 0.100 |
Why?
| | Memory, Short-Term | 1 | 2015 | 250 | 0.100 |
Why?
| | Capillary Permeability | 1 | 2012 | 145 | 0.100 |
Why?
| | Capillaries | 1 | 2012 | 108 | 0.090 |
Why?
| | Bone Marrow Cells | 1 | 2013 | 316 | 0.090 |
Why?
| | Prefrontal Cortex | 1 | 2015 | 301 | 0.090 |
Why?
| | Protein Domains | 2 | 2025 | 289 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 455 | 0.090 |
Why?
| | Fas Ligand Protein | 2 | 2001 | 60 | 0.090 |
Why?
| | Blood Proteins | 1 | 2012 | 252 | 0.090 |
Why?
| | Lysine | 1 | 2012 | 294 | 0.080 |
Why?
| | Epithelial Cells | 3 | 2000 | 1096 | 0.080 |
Why?
| | Mice, Inbred C3H | 2 | 2000 | 269 | 0.080 |
Why?
| | Membrane Proteins | 2 | 2013 | 1164 | 0.080 |
Why?
| | Tumor Cells, Cultured | 3 | 2016 | 955 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2013 | 415 | 0.080 |
Why?
| | Anxiety | 1 | 2016 | 1035 | 0.080 |
Why?
| | Cell Cycle | 2 | 2011 | 601 | 0.080 |
Why?
| | Mutation | 4 | 2015 | 3958 | 0.070 |
Why?
| | Neurodegenerative Diseases | 1 | 2010 | 135 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2016 | 938 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2000 | 367 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2012 | 771 | 0.070 |
Why?
| | Erythroid Precursor Cells | 1 | 2007 | 5 | 0.070 |
Why?
| | Chimera | 1 | 2007 | 58 | 0.070 |
Why?
| | Myeloid Progenitor Cells | 1 | 2007 | 17 | 0.070 |
Why?
| | Neurogenesis | 1 | 2009 | 149 | 0.070 |
Why?
| | Animals, Newborn | 3 | 2016 | 844 | 0.070 |
Why?
| | Middle Aged | 3 | 2025 | 33479 | 0.070 |
Why?
| | Sequence Deletion | 1 | 2007 | 183 | 0.070 |
Why?
| | Cell Count | 1 | 2007 | 324 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 385 | 0.070 |
Why?
| | Cognition | 1 | 2014 | 1153 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2021 | 10811 | 0.060 |
Why?
| | Myeloid Cells | 1 | 2007 | 148 | 0.060 |
Why?
| | Exons | 1 | 2007 | 355 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 2012 | 927 | 0.060 |
Why?
| | Male | 7 | 2025 | 67762 | 0.060 |
Why?
| | Bone Marrow | 1 | 2007 | 286 | 0.060 |
Why?
| | Cell Death | 1 | 2007 | 374 | 0.060 |
Why?
| | Models, Biological | 1 | 2013 | 1783 | 0.060 |
Why?
| | Nerve Tissue Proteins | 3 | 2016 | 596 | 0.060 |
Why?
| | Adult | 3 | 2025 | 37929 | 0.060 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2001 | 224 | 0.060 |
Why?
| | Myeloproliferative Disorders | 1 | 2005 | 27 | 0.060 |
Why?
| | Mesonephros | 1 | 2004 | 3 | 0.060 |
Why?
| | Galactosides | 1 | 2004 | 5 | 0.060 |
Why?
| | Signaling Lymphocytic Activation Molecule Family | 1 | 2004 | 7 | 0.050 |
Why?
| | Killer Cells, Natural | 2 | 2004 | 449 | 0.050 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2004 | 52 | 0.050 |
Why?
| | Antigens, CD34 | 1 | 2004 | 88 | 0.050 |
Why?
| | Leukocyte Common Antigens | 1 | 2004 | 87 | 0.050 |
Why?
| | Biomarkers | 2 | 2013 | 4149 | 0.050 |
Why?
| | Phenotype | 4 | 2013 | 3196 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2025 | 570 | 0.050 |
Why?
| | In Situ Hybridization | 1 | 2004 | 316 | 0.050 |
Why?
| | Gene Transfer Techniques | 1 | 2004 | 170 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2004 | 239 | 0.050 |
Why?
| | Cell Nucleus Structures | 1 | 2003 | 4 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2021 | 3412 | 0.050 |
Why?
| | Nucleosomes | 1 | 2025 | 155 | 0.050 |
Why?
| | Polycomb-Group Proteins | 1 | 2023 | 28 | 0.050 |
Why?
| | Stem Cell Transplantation | 1 | 2004 | 176 | 0.050 |
Why?
| | Myeloid Ecotropic Viral Integration Site 1 Protein | 2 | 2016 | 10 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 767 | 0.050 |
Why?
| | Mice, Inbred CBA | 2 | 2000 | 54 | 0.050 |
Why?
| | DNA | 2 | 2025 | 1459 | 0.040 |
Why?
| | Jurkat Cells | 1 | 2001 | 134 | 0.040 |
Why?
| | Base Sequence | 2 | 2006 | 2181 | 0.040 |
Why?
| | Aorta | 1 | 2004 | 417 | 0.040 |
Why?
| | Time Factors | 3 | 2013 | 6828 | 0.040 |
Why?
| | Models, Immunological | 1 | 2001 | 100 | 0.040 |
Why?
| | Urease | 1 | 2000 | 11 | 0.040 |
Why?
| | Indoles | 1 | 2004 | 412 | 0.040 |
Why?
| | Oncogenes | 1 | 2021 | 116 | 0.040 |
Why?
| | Zebrafish Proteins | 1 | 2003 | 288 | 0.040 |
Why?
| | Genome | 1 | 2023 | 300 | 0.040 |
Why?
| | Liver | 2 | 2011 | 1943 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2021 | 207 | 0.040 |
Why?
| | Helicobacter Infections | 1 | 2000 | 32 | 0.040 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2000 | 41 | 0.040 |
Why?
| | Receptors, Interleukin-10 | 1 | 2000 | 7 | 0.040 |
Why?
| | Drug Design | 1 | 2021 | 167 | 0.040 |
Why?
| | Drug Discovery | 1 | 2021 | 142 | 0.040 |
Why?
| | Lymphoid Tissue | 1 | 2000 | 75 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2005 | 712 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2021 | 476 | 0.040 |
Why?
| | Th1 Cells | 1 | 2000 | 143 | 0.040 |
Why?
| | Clone Cells | 1 | 2000 | 265 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1738 | 0.040 |
Why?
| | Gene Targeting | 1 | 2019 | 81 | 0.040 |
Why?
| | DNA Primers | 1 | 2000 | 515 | 0.040 |
Why?
| | Gastritis | 1 | 2000 | 108 | 0.040 |
Why?
| | Ligands | 1 | 2001 | 664 | 0.040 |
Why?
| | Zebrafish | 1 | 2003 | 499 | 0.040 |
Why?
| | Protein Biosynthesis | 1 | 2001 | 433 | 0.040 |
Why?
| | Up-Regulation | 1 | 2001 | 843 | 0.040 |
Why?
| | Immunity, Cellular | 1 | 2000 | 268 | 0.040 |
Why?
| | Loss of Heterozygosity | 1 | 2016 | 51 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2000 | 789 | 0.030 |
Why?
| | Models, Molecular | 1 | 2021 | 1570 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2003 | 2833 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2016 | 176 | 0.030 |
Why?
| | Locomotion | 1 | 2016 | 106 | 0.030 |
Why?
| | Prosencephalon | 1 | 2015 | 48 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2001 | 879 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2000 | 890 | 0.030 |
Why?
| | Pyramidal Cells | 1 | 2015 | 74 | 0.030 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 158 | 0.030 |
Why?
| | Cell Membrane | 2 | 2012 | 738 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 327 | 0.030 |
Why?
| | Genotype | 2 | 2013 | 1916 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2000 | 1091 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2013 | 44 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2013 | 83 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2013 | 67 | 0.030 |
Why?
| | Caveolae | 1 | 2012 | 18 | 0.030 |
Why?
| | Protein-Losing Enteropathies | 1 | 2012 | 10 | 0.030 |
Why?
| | Antipsychotic Agents | 1 | 2014 | 194 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 171 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1276 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 2016 | 468 | 0.020 |
Why?
| | Cytokines | 1 | 2000 | 2085 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2015 | 501 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2014 | 433 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 320 | 0.020 |
Why?
| | Integrases | 1 | 2011 | 120 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4030 | 0.020 |
Why?
| | Schizophrenia | 1 | 2014 | 439 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2016 | 803 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1502 | 0.020 |
Why?
| | Molecular Sequence Data | 2 | 2005 | 2900 | 0.020 |
Why?
| | Translocation, Genetic | 1 | 2010 | 105 | 0.020 |
Why?
| | Oligodendrocyte Transcription Factor 2 | 1 | 2009 | 21 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1226 | 0.020 |
Why?
| | Antigens, Surface | 2 | 2005 | 154 | 0.020 |
Why?
| | Cell Separation | 2 | 2005 | 318 | 0.020 |
Why?
| | Neuroglia | 1 | 2009 | 173 | 0.020 |
Why?
| | Olfactory Bulb | 1 | 2009 | 93 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 243 | 0.020 |
Why?
| | Fetus | 1 | 2011 | 806 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 2189 | 0.020 |
Why?
| | Coronaviridae Infections | 1 | 1986 | 3 | 0.020 |
Why?
| | G(M1) Ganglioside | 1 | 1986 | 7 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 2006 | 164 | 0.020 |
Why?
| | Blotting, Southern | 1 | 2005 | 73 | 0.020 |
Why?
| | Cell Transplantation | 1 | 2005 | 37 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4295 | 0.020 |
Why?
| | Transgenes | 1 | 2005 | 180 | 0.010 |
Why?
| | CREB-Binding Protein | 1 | 2005 | 31 | 0.010 |
Why?
| | Mesoderm | 1 | 2005 | 144 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2006 | 378 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1774 | 0.010 |
Why?
| | Spleen | 1 | 2005 | 514 | 0.010 |
Why?
| | Body Patterning | 1 | 2003 | 132 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2003 | 534 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 7635 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 225 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 239 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 2000 | 88 | 0.010 |
Why?
| | HLA-DQ Antigens | 1 | 2000 | 181 | 0.010 |
Why?
| | HLA-DR Antigens | 1 | 2000 | 228 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1353 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2003 | 706 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2003 | 2139 | 0.010 |
Why?
| | Binding Sites | 1 | 2000 | 1303 | 0.010 |
Why?
| | Kidney | 1 | 2003 | 1468 | 0.010 |
Why?
| | Aged | 1 | 2014 | 23961 | 0.010 |
Why?
| | Centrifugation, Density Gradient | 1 | 1986 | 41 | 0.000 |
Why?
| | Glycosphingolipids | 1 | 1986 | 7 | 0.000 |
Why?
| | Mice, Inbred A | 1 | 1986 | 49 | 0.000 |
Why?
| | Immune Sera | 1 | 1986 | 88 | 0.000 |
Why?
| | Mice, Inbred DBA | 1 | 1986 | 200 | 0.000 |
Why?
| | Epithelium | 1 | 1986 | 313 | 0.000 |
Why?
| | Colitis | 1 | 1986 | 266 | 0.000 |
Why?
|
|
Ernst's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|